Fresh Fundings 🥧
Recent Equity Rounds
💰 Cera Achieves Unicorn Status with $150 Million Funding
UK-based healthcare startup Cera raised $150 million, led by BDT & MSD Partners and Schroders Capital, pushing its valuation past $1 billion. Funds will expand AI-driven home care services.
💰 Fazeshift Raises $4 Million in Seed Funding
San Francisco-based AI accounts receivable startup Fazeshift secured $4 million in seed funding, led by Gradient with Y Combinator and Wayfinder participation.
💰 Accel Launches $650 Million Fund for India and Southeast Asia
Accel announced a $650 million early-stage fund to back startups in enterprise, SaaS, and consumer sectors in India and Southeast Asia.
Notable Credit Transactions (January)
💳 $190M Facility – Aypa Power
Aypa Power secured a $190 million facility, including a $68 million construction-to-term loan and $91 million tax equity bridge loan, to advance its utilities projects.
💳 $850M Revolver – Ladder Capital
Ladder Capital obtained an $850 million revolving credit facility with participation from major banks, including JPMorgan Chase and Wells Fargo, enhancing its lender finance capabilities.
💳 $35M Loan – Onkos Surgical
Onkos Surgical raised $35 million in venture loan financing from Horizon Technology Finance to expand its medical device innovations in surgical oncology.
💳 $265M Senior Secured Facility – Consumer Products Distributor
An undisclosed distributor received $265 million in senior secured credit from Eclipse Business Capital to bolster its supply chain operations.
💳 $100M Credit Facility – Advanced Power
Advanced Power secured a $100 million facility from Nomura Securities and Sumitomo Mitsui Banking to support its infrastructure development initiatives.
👨💻 $1.25M Term Loan – Engineering software solutions provider in Texas
👕 $5M ABL Revolver – Apparel and promotions company in Iowa
🏥 $800K Term Loan –Commercial property for a midwest-based pharmacy network
🚪 $2M ABL Revolver – Innovative building materials supplier in Delaware
Recent M&A
♟️ Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion – Johnson & Johnson has reached a $14.6 billion agreement to acquire Intra-Cellular Therapies, a biotech company specializing in neuroscience. This acquisition marks the largest biotech buyout in over a year and aims to enhance J&J's presence in brain disease treatments.
♟️ Stryker Acquires Inari Medical for $4.9 Billion – Stryker confirmed its $4.9 billion acquisition of Inari Medical, a company specializing in devices treating venous thromboembolism. This strategic move is expected to enhance Stryker’s neurovascular product line.
♟️ Later Acquires Mavely for $250 Million – Later, a social media marketing company, acquired Mavely, a platform facilitating commission payments to social media creators for direct sales, for $250 million. This acquisition is part of a trend of consolidation within the influencer marketing industry.
New Businesses for Sale
🛒 Healthcare Tech Company – $585K ARR with 26% Growth
A San Francisco-based AI-powered health tech business specializing in patient engagement solutions. The company generates 90% of its revenue from product licenses, boasting an 89% retention rate for high-value clients. Operating remotely with global reach in Southeast Asia and MENA, this scalable business offers AI-driven tools for real-time feedback, analytics, and communication. Established in 2014, it achieved $580K in revenue with $227K cash flow last year. See on BizBuySell.
🛒 SaaS iPaaS Platform – $729K Revenue, 16 Years in Business
This 16-year-old Integration Platform as a Service (iPaaS) focuses on Salesforce and NetSuite integrations, generating $729K annually with a 72% profit margin. With 3,484 active subscribers, a low 1.5% monthly churn, and strong organic growth, the business serves clients across 21+ industries. Operated remotely with a team in the Philippines, the company maintains a stellar 4:1 LTV to CAC ratio, positioning it for significant scale. See on Flippa.
We also want to celebrate a great 2024 for Cirrus' clients and partners!